The chemical class known as HMG-17 inhibitors comprises a diverse range of compounds designed to modulate the activity of HMG-17, a member of the high-mobility group (HMG) family of proteins. These proteins play integral roles in chromatin structure, gene expression, and other nuclear processes. HMG-17, in particular, has been implicated in various cellular functions due to its ability to bind to DNA and influence chromatin organization. HMG-17 inhibitors are characterized by their capability to interact with specific regions or domains of HMG-17, effectively disrupting its DNA-binding activity and altering its influence on chromatin architecture and gene regulation. Structurally, HMG-17 inhibitors encompass a broad spectrum of chemical entities, including natural compounds and synthetic molecules. These inhibitors are designed with careful consideration of the binding interfaces and interaction sites of HMG-17 involved in DNA recognition. Often, they feature chemical groups that facilitate interactions with key residues in the DNA-binding region of HMG-17. By effectively binding to this protein, these inhibitors aim to prevent or weaken its affinity for DNA, thereby impacting the functional roles of HMG-17 in gene expression and chromatin dynamics.
The development of HMG-17 inhibitors involves a multidisciplinary approach, combining computational modeling, structural biology, and chemical synthesis. Researchers work to optimize the chemical structures of these compounds, aiming to enhance their binding affinity, specificity, and overall inhibitory potency against HMG-17. Iterative design and testing are critical in refining these inhibitors to achieve the desired modulation of HMG-17 activity. Upon synthesis, HMG-17 inhibitors undergo rigorous biochemical characterization and cellular studies to validate their inhibitory effects. These studies often involve assessing changes in DNA-HMG-17 interactions, chromatin structure, and downstream gene expression patterns upon HMG-17 inhibition. By elucidating the impact of HMG-17 inhibition on cellular processes, researchers gain insights into the roles of this protein in fundamental biological mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine has been studied for its ability to inhibit the DNA-binding activity of HMG-17, potentially affecting chromatin organization and gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural compound found in turmeric, has been suggested to have inhibitory effects on HMG-17, potentially influencing its role in chromatin structure and gene expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid abundant in many plant-based foods, has been studied for its potential to modulate the interaction between HMG-17 and DNA. | ||||||
Rutin trihydrate | 250249-75-3 | sc-204897 sc-204897A sc-204897B | 5 g 50 g 100 g | $57.00 $72.00 $126.00 | 7 | |
Rutin, another flavonoid, has been investigated for its ability to affect HMG-17's DNA-binding activity, potentially altering its role in chromatin organization. | ||||||
Caffeic Acid | 331-39-5 | sc-200499 sc-200499A | 1 g 5 g | $32.00 $62.00 | 1 | |
Caffeic acid, a phenolic compound found in various plants, has been studied for its effects on HMG-17's DNA-binding properties. | ||||||